Ryan Murphy is the latest A-list producer to sign with Netflix. ZIMBIO's Areeba Abid joins Cheddar to discuss whether the mogul is worth a reported $300 million price tag. Murphy is the creative mind behind hits such as "Glee," "American Horror Story," and "American Crime Story." The payday is drawing some criticism for reportedly coming in much higher than Shonda Rhimes' Netflix deal. Abid explains why she thinks Netflix should offer the Grey's Anatomy producer more money in light of the recent news. We discuss how the development fits in with the wage-gap controversy surrounding the "All the Money in the World" reshoots. Then, we hit on two of the biggest feuds engulfing Hollywood and Washington D.C. Abid speaks to how beneficial Omarosa has been for "Big Brother's" return to relevance. We also pick up the pieces from the latest twist in Kim Cattrall's social media battle with Sarah Jessica Parker.

Share:
More In Culture
Bed Bath & Beyond's Stock Jumps Despite Earnings Miss as Meme Stock Mania Reappears
Bed Bath & Beyond delivered disappointing fiscal third-quarter results for 2022. Shares initially dove more than 9% in premarket trading on the news but finished the day up nearly 8%. Bed Bath & Beyond has been a meme-stock target for online investors in the past -- so was meme-stock mania a factor in the recent stock movement for the company? Jaime Rogozinski, the founder of the subreddit WallStreetBets, joins Cheddar News' Closing Bell for more, as his forum helped spark the meme stock phenomena. He also discussed some decentralized finance services and trends for the retail investor to watch for in 2022.
Pear Therapeutics CEO on How Its Apps Work for Conditions Like Addiction
Digital medical care provider Pear Therapeutics rang the closing bell on the Nasdaq Friday and President and CEO Dr. Corey McCann, joined Cheddar to talk about how the company plans to grow the business of software-based therapeutics and how the first FDA authorized prescription digital therapeutics company will go about treating illnesses like insomnia and addiction. "These really are pieces of software. In many cases, they're apps and in the cases of our addiction products, these are based on something called cognitive behavioral therapy or CBT," he said. "These products change the patient's brain circuitry to help them be abstinent, to help them stay in treatment, and that's exactly what we see in randomized clinical trials and that's what we see in the real world." He also addressed the ongoing mental health crises brought on by the pandemic. **copy updated to remove IPO information as Pear Therapeutics went public in December**
Bitcoin Price Tumbles First Week of 2022
Ben Armstrong, founder of Bitboy Crypto, joins Cheddar News to discuss Bitcoin's downward trend and what's next for crypto after protests in Kazakhstan cause crypto miners to shut down.
Pearson CEO Says Flexibility Is Key to Maximize Remote Instruction for Students
The highly transmissible omicron variant of COVID-19 has forced school districts nationwide to return to virtual instruction, but there remain concerns about the quality of education students are receiving online. Andy Bird, CEO of Pearson, an education publisher and assessment service provider, joined Cheddar's "Opening Bell" to talk about steps educators and parents can take to make the remote learning experience an easier one, noting that one of the biggest advantages teachers can have is flexibility. "You cannot take a rigid timetable that works in the analog world and replicate that in the digital world. You need to have flexibility. Asynchronous learning, I think, is a very important part," he told Cheddar.
Load More